Scheduled On : Tuesday, October 15, 2013 at 1:00 PM EDT
Duration: 60 minutes
This webinar is recorded
visit us at https://www.compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=MD1112
Elexes medical consulting webinar- 510(k) SubmissionsJenniferGantt
This webinar presentation provides an overview of the key elements of a 510(k) submission process for medical devices in the United States. It discusses the concept and types of 510(k) clearances, FDA review stages, considerations for performance and software testing, common questions, and tips for a successful 510(k). The presentation aims to help medical device companies understand the requirements and expectations for obtaining a 510(k) clearance from the FDA.
5 Things To Consider When Making A Change To An Existing Medical DeviceEMMAIntl
In this constantly changing world, it is important that your products keep up with the latest technology available. With medical devices now being in the form of wearables, long gone are the days when patients needed to be hooked up to a system to monitor their health.
Continuously improving your product requires you to make changes, and some of these changes may require notifying the FDA in the form of supplemental reports, 510(k)s, etc...
The document announces a webinar on regulatory documents for medical devices, including the Design History File, Device Master Record, Device History Record, and Technical File. The webinar will cover ensuring these documents are accurate, accessible to operators, and contain all required production and testing data. It will take place on February 29, 2012 from 1-2pm EST. Early bird discounts are available using the promo code "CGO15". The speaker is Angela Bazigos, CEO of Touchstone Technologies, with almost 30 years of experience in the life sciences industry.
As part of device description, required by 21 CFR 807.92(a)(4), medical device manufacturers will have to present how the device functions, the scientific concepts that form the basis for the device, and the significant physical and performance characteristics of the device, such as device design, materials used, physical, chemical and biological properties.
For the most part, everyone in the medical device industry is familiar with the term “510(k)”, but not many people know that there are three different types of the premarket notification. The following are the different types of 510(k)’s a firm can submit: Traditional, special, and abbreviated. Each 510(k) is a premarket notification, which if cleared, grants the firm permission by the FDA to market the device; but each one has different benefits and processes that medical device firms can take advantage of...
Elexes medical consulting webinar- 510(k) SubmissionsJenniferGantt
This webinar presentation provides an overview of the key elements of a 510(k) submission process for medical devices in the United States. It discusses the concept and types of 510(k) clearances, FDA review stages, considerations for performance and software testing, common questions, and tips for a successful 510(k). The presentation aims to help medical device companies understand the requirements and expectations for obtaining a 510(k) clearance from the FDA.
5 Things To Consider When Making A Change To An Existing Medical DeviceEMMAIntl
In this constantly changing world, it is important that your products keep up with the latest technology available. With medical devices now being in the form of wearables, long gone are the days when patients needed to be hooked up to a system to monitor their health.
Continuously improving your product requires you to make changes, and some of these changes may require notifying the FDA in the form of supplemental reports, 510(k)s, etc...
The document announces a webinar on regulatory documents for medical devices, including the Design History File, Device Master Record, Device History Record, and Technical File. The webinar will cover ensuring these documents are accurate, accessible to operators, and contain all required production and testing data. It will take place on February 29, 2012 from 1-2pm EST. Early bird discounts are available using the promo code "CGO15". The speaker is Angela Bazigos, CEO of Touchstone Technologies, with almost 30 years of experience in the life sciences industry.
As part of device description, required by 21 CFR 807.92(a)(4), medical device manufacturers will have to present how the device functions, the scientific concepts that form the basis for the device, and the significant physical and performance characteristics of the device, such as device design, materials used, physical, chemical and biological properties.
For the most part, everyone in the medical device industry is familiar with the term “510(k)”, but not many people know that there are three different types of the premarket notification. The following are the different types of 510(k)’s a firm can submit: Traditional, special, and abbreviated. Each 510(k) is a premarket notification, which if cleared, grants the firm permission by the FDA to market the device; but each one has different benefits and processes that medical device firms can take advantage of...
This webinar discusses best practices for preparing and submitting 510(k) premarket notifications to the FDA in compliance with the agency's eCopy and Refuse to Accept (RTA) Policy requirements. The webinar will provide guidance on putting together a compelling 510(k) package that increases submission quality and expedites FDA review, including how to meet regulatory requirements for performance testing, clinical data, and responding to requests for additional information from FDA reviewers. Attendees will learn about statutes and regulations governing 510(k)s, definitions, indications for use, predicates, standards, submission requirements, and practices to avoid or follow for successful clearances.
Webinar or Online Training on A comprehensive overview of 510(k) submissionComplianz World
Complianz World is a US based company, and a leading GRC training provider has announced to conduct
Webinar or Online Training on
A comprehensive overview of 510(k) submission
This webinar will provide valuable guidance to regulated companies in development and implementation of formal, defined, documented methods for analysis of product changes and when to file a new 510(k). Consideration of the U.S . FDA's current K-97-1 Memo / guidance document on "510(k) Device Modifications"
Start Up, Substantial Equivalence (SE), De Novo, and EU-MDR/IVDR Devices have high quality, affordable products that improve the quality of life for their patients. However, this often is associated with austere conditions wherein time and funds are both in short supply. Read https://biotechresearchgroup.com/fda-de-novo-medical-devices/
This session will discuss all the documents used by FDA to train their inspectors to review your CAPA system, some of which you may not be familiar with.
This webinar will discuss medical device changes and the 510(k) process. It will provide guidance on analyzing product changes and determining when a new 510(k) submission is required. The webinar will cover using the FDA's K97-1 guidance document and considering manufacturing, labeling, technical, and material changes. It will also discuss implementing formal change control methods and documenting rationale for 510(k) submissions or non-submissions. The 90-minute webinar presented by John Lincoln will be useful for medical device companies in R&D, engineering, quality, and regulatory roles.
This webinar is intended to help you get familiar with the European Union (EU) Directives governing medical devices including in vitro diagnostic and active implantable medical devices.
This webinar is further intended to provide guidance on the regulatory requirements set out in the applicable Directives, which help assure that medical devices are safe and effective for their intended use.
Premarket Notification 510(k) for Biologics [Autosaved].pptxSusmithaTella2
The document summarizes the key aspects of the 510(k) premarket notification process for biologics. It explains that 510(k) is required to market a new device and demonstrates substantial equivalence to a legally marketed predicate device. The submission must include device descriptions, intended use, and clinical/nonclinical test results. There are three types of 510(k) submissions. The process involves FDA review within 90 days to determine substantial equivalence or request additional information. If cleared, the product can be marketed immediately.
The FDA’s 510(k) process for medical devices is doing a lot of rounds in the news lately. This includes the FDA Commissioner Dr. Scott Gottlieb’s announcement on the renovation to the 510(k) program and two new pilot programs initiated by FDA: the Quality in 510(k) (“Quik”) Review and the Special 510(k) pilot programs. In this week’s blog, we are shedding some light on what you should expect from the Quik 510(k) and the Special 510(k) programs...
The document announces a two-day in-person seminar on preparing for and responding to FDA inspections. The seminar will be held on July 21st and 22nd, 2016 in Cape Town, South Africa and led by regulatory expert David Dills. It will provide fundamentals and best practices for interacting with inspectors, ensuring documentation is in order, responding to inspection findings, and achieving favorable outcomes. Topics include inspection preparation and training, documentation requirements, dos and don'ts for interacting with investigators, and following up after inspections.
This document outlines the agenda for a conference on obtaining FDA approval for AI-based medical devices. The agenda includes presentations on paving the path for FDA approval of AI devices, an open Q&A session with the FDA's Digital Health Center of Excellence, how to align product development with FDA regulations for AI, best pre-submission practices, and an update on the 510(k) program. There will also be breaks and a summary session. The presentations will provide guidance on navigating the FDA approval process for AI medical devices and obtaining feedback prior to formal submissions.
OSMA: Orthopedic Industry's Top Regulatory Challenges and OpportunitiesApril Bright
The Orthopaedic Surgical Manufacturers Association, a collective voice of orthopedic device companies that influences the decision of worldwide regulatory agencies and standards bodies, will highlight the main regulatory changes impacting the industry. This session is for any orthopedic professional who wants a forecast of regulatory pressures and seeks direction on how to shape change. Attendees will learn how FDA, European agencies and IMDRF are approaching harmonization and alignment of standards, regulations and guidance. OSMA Members will provide future trends and opportunities afforded via FDA’s National Evaluation System for Health Technology (NEST), facilitation of innovation through partnerships and global harmonization of regulatory submissions and facility assessments.
Crossroads: U.S. Medical Device Regulation vs. Innovation
The U.S. medical device industry is at a regulatory and potentially economic crossroad as the FDA continues to refine its 510(k) regulatory submission requirements and guidelines. Medical device manufacturers have been urging the FDA and Congress to expedite new product review processes to spur innovation and bring new medical technologies to market faster. However, supporters of stricter FDA regulations claim that a faster regulatory review process causes unsafe devices to enter the market.
As a result of numerous exchanges between both sides of the issue, CDRH (FDA) recently issued multiple updates to its initiatives for the 510(k) approval process. To shed light on key changes, we obtained the support of the office of Dr. Jeffrey Shuren MD JD, Director of CDRH and Dr. John Smith MD JD, of Hogan Lovells, a prominent international law firm with a medical regulatory specialty, on their interpretations of the 510(k) regulatory guidelines and the impact these guidelines will have on medical device manufacturers.
Listen to the Dr. John Smith podcast interview here:
http://youtu.be/iHVpwwXi7dY
The MarkeTech Group
502 Mace Blvd.
Davis, CA 95618
http://www.themarketechgroup.com
The webinar discusses preparing for and handling FDA inspections of clinical research. It covers how to prepare for an FDA inspection, how to respond during one, and possible outcomes like 483 observations or warning letters. The webinar is presented by Lee Truax-Bellows, an experienced regulatory consultant, auditor, and clinical research project manager. Attendees include clinical research managers and staff who want to learn how to properly handle FDA inspections of their research.
Implementing Agile in an FDA Regulated EnvironmentTechWell
Developing medical devices that are subject to FDA approval has traditionally followed the waterfall methodology, largely due to the structure of the regulations that govern development practices. But we know from myriad case studies in different industries that agile methodologies are far superior in providing the highest value to customers in the shortest time to market. Neal Herman shares how one developer of complex medical devices embraced agile software development practices and proved that it could not only develop software faster with higher quality but also meet all regulatory requirements. Convincing the internal quality management, systems engineering, and regulatory departments was difficult, but the software department was able to overcome these obstacles and fundamentally change the company’s philosophy on product development. Since 2012, software development productivity is up 100 percent, and quality is up 200 percent. Now, after seeing these gains from the software department, agile is being rolled out to all areas of R&D including hardware.
The conference will provide insights into quality and systems thinking with a carefully planned program bridging theory to practice. Speakers from Shell, NASA, and the FDA will discuss transforming work processes for quality assurance due to new complexities from advances like the industrial internet. Attendees can learn directly from the experts on quality thinking and applying it in life sciences, healthcare, and other industries. The conference aims to help attendees prepare for the future of their work.
Regulatory1 is a consulting firm that provides regulatory, quality, and compliance services to medical device and pharmaceutical companies. Their services include regulatory strategy, project management, technical documentation preparation for approval, auditing, ISO compliance, clinical trials, testing, and more. They specialize in assisting both large and small clients with FDA and other regulatory requirements. They also offer internal audit services to help companies improve risk management, governance, and controls. Their audit services include regulatory compliance audits, certification support, third party audits, and FDA mock audits.
Project Management for Computer Systems ValidationAnita Anzo
Scheduled On : Thursday, November 7, 2013 at 12:00 noon
Duration: 120 minutes
this webinar is recorded
visit us at https://www.compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=IT1050
Cleaning Validations Using Extraction TechniquesAnita Anzo
Scheduled On : Monday, November 4, 2013 at 1:00 PM EDT
Duration: 60 minutes
this webinar is recorded
visit us at https://www.compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=MD1141
This webinar discusses best practices for preparing and submitting 510(k) premarket notifications to the FDA in compliance with the agency's eCopy and Refuse to Accept (RTA) Policy requirements. The webinar will provide guidance on putting together a compelling 510(k) package that increases submission quality and expedites FDA review, including how to meet regulatory requirements for performance testing, clinical data, and responding to requests for additional information from FDA reviewers. Attendees will learn about statutes and regulations governing 510(k)s, definitions, indications for use, predicates, standards, submission requirements, and practices to avoid or follow for successful clearances.
Webinar or Online Training on A comprehensive overview of 510(k) submissionComplianz World
Complianz World is a US based company, and a leading GRC training provider has announced to conduct
Webinar or Online Training on
A comprehensive overview of 510(k) submission
This webinar will provide valuable guidance to regulated companies in development and implementation of formal, defined, documented methods for analysis of product changes and when to file a new 510(k). Consideration of the U.S . FDA's current K-97-1 Memo / guidance document on "510(k) Device Modifications"
Start Up, Substantial Equivalence (SE), De Novo, and EU-MDR/IVDR Devices have high quality, affordable products that improve the quality of life for their patients. However, this often is associated with austere conditions wherein time and funds are both in short supply. Read https://biotechresearchgroup.com/fda-de-novo-medical-devices/
This session will discuss all the documents used by FDA to train their inspectors to review your CAPA system, some of which you may not be familiar with.
This webinar will discuss medical device changes and the 510(k) process. It will provide guidance on analyzing product changes and determining when a new 510(k) submission is required. The webinar will cover using the FDA's K97-1 guidance document and considering manufacturing, labeling, technical, and material changes. It will also discuss implementing formal change control methods and documenting rationale for 510(k) submissions or non-submissions. The 90-minute webinar presented by John Lincoln will be useful for medical device companies in R&D, engineering, quality, and regulatory roles.
This webinar is intended to help you get familiar with the European Union (EU) Directives governing medical devices including in vitro diagnostic and active implantable medical devices.
This webinar is further intended to provide guidance on the regulatory requirements set out in the applicable Directives, which help assure that medical devices are safe and effective for their intended use.
Premarket Notification 510(k) for Biologics [Autosaved].pptxSusmithaTella2
The document summarizes the key aspects of the 510(k) premarket notification process for biologics. It explains that 510(k) is required to market a new device and demonstrates substantial equivalence to a legally marketed predicate device. The submission must include device descriptions, intended use, and clinical/nonclinical test results. There are three types of 510(k) submissions. The process involves FDA review within 90 days to determine substantial equivalence or request additional information. If cleared, the product can be marketed immediately.
The FDA’s 510(k) process for medical devices is doing a lot of rounds in the news lately. This includes the FDA Commissioner Dr. Scott Gottlieb’s announcement on the renovation to the 510(k) program and two new pilot programs initiated by FDA: the Quality in 510(k) (“Quik”) Review and the Special 510(k) pilot programs. In this week’s blog, we are shedding some light on what you should expect from the Quik 510(k) and the Special 510(k) programs...
The document announces a two-day in-person seminar on preparing for and responding to FDA inspections. The seminar will be held on July 21st and 22nd, 2016 in Cape Town, South Africa and led by regulatory expert David Dills. It will provide fundamentals and best practices for interacting with inspectors, ensuring documentation is in order, responding to inspection findings, and achieving favorable outcomes. Topics include inspection preparation and training, documentation requirements, dos and don'ts for interacting with investigators, and following up after inspections.
This document outlines the agenda for a conference on obtaining FDA approval for AI-based medical devices. The agenda includes presentations on paving the path for FDA approval of AI devices, an open Q&A session with the FDA's Digital Health Center of Excellence, how to align product development with FDA regulations for AI, best pre-submission practices, and an update on the 510(k) program. There will also be breaks and a summary session. The presentations will provide guidance on navigating the FDA approval process for AI medical devices and obtaining feedback prior to formal submissions.
OSMA: Orthopedic Industry's Top Regulatory Challenges and OpportunitiesApril Bright
The Orthopaedic Surgical Manufacturers Association, a collective voice of orthopedic device companies that influences the decision of worldwide regulatory agencies and standards bodies, will highlight the main regulatory changes impacting the industry. This session is for any orthopedic professional who wants a forecast of regulatory pressures and seeks direction on how to shape change. Attendees will learn how FDA, European agencies and IMDRF are approaching harmonization and alignment of standards, regulations and guidance. OSMA Members will provide future trends and opportunities afforded via FDA’s National Evaluation System for Health Technology (NEST), facilitation of innovation through partnerships and global harmonization of regulatory submissions and facility assessments.
Crossroads: U.S. Medical Device Regulation vs. Innovation
The U.S. medical device industry is at a regulatory and potentially economic crossroad as the FDA continues to refine its 510(k) regulatory submission requirements and guidelines. Medical device manufacturers have been urging the FDA and Congress to expedite new product review processes to spur innovation and bring new medical technologies to market faster. However, supporters of stricter FDA regulations claim that a faster regulatory review process causes unsafe devices to enter the market.
As a result of numerous exchanges between both sides of the issue, CDRH (FDA) recently issued multiple updates to its initiatives for the 510(k) approval process. To shed light on key changes, we obtained the support of the office of Dr. Jeffrey Shuren MD JD, Director of CDRH and Dr. John Smith MD JD, of Hogan Lovells, a prominent international law firm with a medical regulatory specialty, on their interpretations of the 510(k) regulatory guidelines and the impact these guidelines will have on medical device manufacturers.
Listen to the Dr. John Smith podcast interview here:
http://youtu.be/iHVpwwXi7dY
The MarkeTech Group
502 Mace Blvd.
Davis, CA 95618
http://www.themarketechgroup.com
The webinar discusses preparing for and handling FDA inspections of clinical research. It covers how to prepare for an FDA inspection, how to respond during one, and possible outcomes like 483 observations or warning letters. The webinar is presented by Lee Truax-Bellows, an experienced regulatory consultant, auditor, and clinical research project manager. Attendees include clinical research managers and staff who want to learn how to properly handle FDA inspections of their research.
Implementing Agile in an FDA Regulated EnvironmentTechWell
Developing medical devices that are subject to FDA approval has traditionally followed the waterfall methodology, largely due to the structure of the regulations that govern development practices. But we know from myriad case studies in different industries that agile methodologies are far superior in providing the highest value to customers in the shortest time to market. Neal Herman shares how one developer of complex medical devices embraced agile software development practices and proved that it could not only develop software faster with higher quality but also meet all regulatory requirements. Convincing the internal quality management, systems engineering, and regulatory departments was difficult, but the software department was able to overcome these obstacles and fundamentally change the company’s philosophy on product development. Since 2012, software development productivity is up 100 percent, and quality is up 200 percent. Now, after seeing these gains from the software department, agile is being rolled out to all areas of R&D including hardware.
The conference will provide insights into quality and systems thinking with a carefully planned program bridging theory to practice. Speakers from Shell, NASA, and the FDA will discuss transforming work processes for quality assurance due to new complexities from advances like the industrial internet. Attendees can learn directly from the experts on quality thinking and applying it in life sciences, healthcare, and other industries. The conference aims to help attendees prepare for the future of their work.
Regulatory1 is a consulting firm that provides regulatory, quality, and compliance services to medical device and pharmaceutical companies. Their services include regulatory strategy, project management, technical documentation preparation for approval, auditing, ISO compliance, clinical trials, testing, and more. They specialize in assisting both large and small clients with FDA and other regulatory requirements. They also offer internal audit services to help companies improve risk management, governance, and controls. Their audit services include regulatory compliance audits, certification support, third party audits, and FDA mock audits.
Project Management for Computer Systems ValidationAnita Anzo
Scheduled On : Thursday, November 7, 2013 at 12:00 noon
Duration: 120 minutes
this webinar is recorded
visit us at https://www.compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=IT1050
Cleaning Validations Using Extraction TechniquesAnita Anzo
Scheduled On : Monday, November 4, 2013 at 1:00 PM EDT
Duration: 60 minutes
this webinar is recorded
visit us at https://www.compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=MD1141
21 CFR 11 Compliance for Excel SpreadsheetsAnita Anzo
Scheduled On : Tuesday, October 22, 2013 at 12:00 noon EDT
Duration: 120 Minutes
this webinar is recorded
visit us at https://www.compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=FDB1051
Creating Design History Files (DHF), the Device Master Records (DMR) and the ...Anita Anzo
Scheduled On : Friday, October 18, 2013 at 1:00 PM EDT
Duration: 60 minutes
this webinar is recorded
visit us at https://www.compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=MD1042
Scheduled On : Thursday, October 10, 2013 at 01:00 PM EDT
Duration: 90 Minutes
This webinar is recorded
visit us at https://www.compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=MD1130
Marketing FDA Regulated Products Through Social MediaAnita Anzo
Scheduled On Wednesday, October 9, 2013 at 01:00 PM EDT
Duration: 90 minutes
This webinar is recorded
visit us at https://www.compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=FDB1103
21 CFR Part 820 - Quality System Regulation - Applying Principles of Lean Doc...Anita Anzo
Scheduled On : Wednesday, July 24, 2013 at 1:00 PM EDT
Duration : 60 Minutes
In this webinar, we apply the Theory of Lean documents and its corollary Theory of Lean Configuration to present a fresh approach to following 21 CFR Part 820, yet is based on solid principles and proven practices.
How to manage virtual employees and achieve real results… any time… any placeAnita Anzo
Scheduled On : Tuesday, July 23, 2013 at 1:00 PM EDT
Duration: 60 minutes
In this 60 minute webinar, Tamara shares actual work experience of being a successful remote employee and remote manager in less than ideal circumstances and learning through experimentation and error, the most effective development of everybody in an organization.
How to Manage a Product Medical Device Recall Efficiently and EffectivelyAnita Anzo
Scheduled On : Thursday, July 18, 2013 at 1:00 PM EDT
This webinar will provide valuable assistance and guidance to medical device firms that are either going through or preparing to go through a recall and want to understand the strategy and expectations of a recall and FDA's involvement.
Construct and manage the technical file and design dossierAnita Anzo
Scheduled On : Tuesday, July 16, 2013 at 1:00 PM EDT
This Webinar will provide a substantive overview and outline the differences between the Technical File and Design Dossier for those device firms dealing with the global regulatory landscape.
Creating Value: Employee Engagement at WorkAnita Anzo
Scheduled On Wednesday, July 10, 2013 at 1:00 PM EDT
This detailed 90 minute discussion will cover the “rules of engagement”, what constitutes engagement, and the keys to insuring that once engaged it is in the right spirit for the right outcomes. Stepping through an entire engagement initiative, participants will engage in thoughts that will help them craft an engagement policy, program and objectives for success in their own company culture and with their own future.
The Hitchhiker’s guide to 483s and warning lettersAnita Anzo
Regulatory Inspections are performed by various agencies to assure that anyone involved in the lifecycle of a pharmaceutical / biotech / medical device product, abides by the laws and regulations. This affects the entire supply chain.
A fun way to present this serious topic !
Whether your business can affect drug safety and effectiveness, Cosmetic and Medical specialized and consumer products your business is regulated by the FDA.
With the FDA regulating a trillion worth of products each year, it is no wonder that audits by the FDA are perhaps the most intimidating of all events at a regulated facility.
483's and their more serious counterparts, Warning Letters, are Citations issued by the FDA as a result of issues uncovered during an Inspection.
In 2011 alone, there were 9288 product recalls, 16 Injunctions and 15 seizures.
Can you afford not to be prepared ?
This presentation will use humor to describe:
> Why the FDA issues such citations
> What is a 483 and what does it look like
> What is a Warning letter and what does it look like
> What is the difference between a 483 and a Warning Letter
> What they mean for your company
> How to respond to 483s and Warning Letters to avoid escalation by the FDA
> How to prevent future issues during inspection and avoid future issuances of 483s and Warning Letters
The Hitchhiker’s guide to 483s and warning letters
510k for IVDs
1. Contact Us : +1-416-915-4458
We Empower, You Comply!
Webiar Description:
Areas Covered in the Session :
Who Will Benefit:
Speaker Profile:
public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author. Dr. Lim leads
and directs all research projects including pharmacovigilance, medical device reporting, recalls and patient safety signals
being conducted at the Regulatory Doctor.
This webinar is intended to demonstrate 510(k) contents and format including 510(k) processesin accordance with FDA’s
eCopy and RTA policy, helping you streamline your 510(k) preparation, submission and successful clearance for IVDs,
saving days, weeks or months of your time and efforts.
Although it is believed there may be various factors contributing to those nine (9) 510(k) clearances taking longer than 90
days, it is imperative more than ever from our industry perspectives that the medical device manufacturers understand
recent changes (hurdles and new requirements) and be able to prepare a 510(k) in a sufficiently adequate way to
expedite the review process, leading successful clearances without delays.
In this webinar, speaker will discuss what and how to do with your 510(k) preparation and submission. In particular, the
speaker will share what he has learned from his own experience and also based on his analysis of the above-mentioned
nine (9) IVD 510(k)s cleared in August, 2013.
To register for this webinar please visit our website www.compliancetrainings.com
510(k) for IVDs
Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor
(www.RegulatoryDoctor.com). Dr. Lim frequently presents global regulatory and quality compliance
topics in various forums and meetings. Recently, Dr. Lim developed 510(k) templates ready for use
compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for
drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in
483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA)
through public comments and also served as a panel member during the FDA’s transparency
Tuesday, October 15, 2013
Duration : 60 Minutes
10:00 AM PDT | 01:00 PM EDT
Speaker | Dr. David Lim
> Statute(s) and regulations
> Regulatory requirements for 510(k)s
> Device classification and predicates
> When 510(k)s are required
> Demonstrating substantial equivalence
> Recent 510(k) changes and requirements including e-Copy and RTA policy
> Regulatory requirements for IVDs
> Standards and guidance applicable to IVDs
> How to address and present performance data and/or clinical data in a succinct, comprehensive manner.
> How to respond to FDA’s request of additional information.
> How to resolve different opinions between the submitter and FDA reviewer(s)
To register for this webinar please visit our website www.compliancetrainings.com
> RA
> R&D and CROs
> QA/QC/QS
> Consultants
> Contractors/subcontractors
> Senior management
> Anyone interested in 510(k) matters